Publicação
The influence of rheumatoid arthritis disease characteristics on heart failure
| dc.contributor.author | Myasoedova, Elena | |
| dc.contributor.author | Crowson, Cynthia S. | |
| dc.contributor.author | Nicola, Paulo J. | |
| dc.contributor.author | Maradit-Kremers, Hilal | |
| dc.contributor.author | Davis, John M. | |
| dc.contributor.author | Roger, Véronique L. | |
| dc.contributor.author | Therneau, Terry M. | |
| dc.contributor.author | Gabriel, Sherine E. | |
| dc.date.accessioned | 2016-08-05T14:33:12Z | |
| dc.date.available | 2016-08-05T14:33:12Z | |
| dc.date.issued | 2011-08 | |
| dc.description | The Journal of Rheumatology Copyright © 2011. All rights reserved. | pt_PT |
| dc.description.abstract | Objective To examine the impact of rheumatoid arthritis (RA) characteristics and antirheumatic medications on the risk of heart failure (HF) in RA. Methods A population-based incidence cohort of RA patients aged ≥18 (1987 ACR criteria first met between 1/1/1980 and 1/1/2008) without a history of HF was followed until HF onset (defined by Framingham criteria), death, or 1/1/2008. We collected data on RA characteristics, antirheumatic medications and cardiovascular (CV) risk factors. Cox models adjusting for age, sex and calendar year were used to analyze the data. Results The study included 795 RA patients (mean age 55.3 years, 69% females, 66% rheumatoid factor [RF] positive). During the mean follow-up of 9.7 years, 92 patients developed HF. The risk of HF was associated with RF positivity (HR 1.6, 95%CI 1.0, 2.5), erythrocyte sedimentation rate (ESR) at RA incidence (HR 1.6, 95%CI 1.2, 2.0), repeatedly high ESR (HR 2.1, 95%CI 1.2, 3.5), severe extra-articular manifestations (HR 3.1, 95%CI 1.9, 5.1) and corticosteroid use (HR 2.0, 95%CI 1.3, 3.2), adjusting for CV risk factors and coronary heart disease (CHD). Methotrexate users were half as likely to have HF as non-users (HR 0.5, 95%CI 0.3, 0.9). Conclusion Several RA characteristics and the use of corticosteroids were associated with HF adjusting for CV risk factors and CHD. Methotrexate use appeared to be protective against HF. These findings suggest an independent impact of RA on HF which may be further modified by antirheumatic treatment. | pt_PT |
| dc.identifier.citation | J Rheumatol. 2011 Aug; 38 (8): 1601–1606. | pt_PT |
| dc.identifier.doi | 10.3899/jrheum.100979 | pt_PT |
| dc.identifier.issn | 0315-162X | |
| dc.identifier.uri | http://hdl.handle.net/10451/24478 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | The Journal of Rheumatology | pt_PT |
| dc.relation.publisherversion | http://www.jrheum.org/ | pt_PT |
| dc.subject | Rheumatoid arthritis | pt_PT |
| dc.subject | Heart failure | pt_PT |
| dc.subject | Determinants | pt_PT |
| dc.title | The influence of rheumatoid arthritis disease characteristics on heart failure | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | The Journal of Rheumatology | pt_PT |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |